Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Hyloris Pharmaceuticals SA - Filing #3166143

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
15,380,000 EUR
11,901,000 EUR
Revenue
2,087,000 EUR
900,000 EUR
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
12,808,000 EUR
13,020,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
9,889,000 EUR
11,373,000 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
131,000 EUR
7,838,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.